A comparative study of the effects of isoetharine and some other adrenergic beta-stimulators in chronic obstructive lung disease.
D000284:Administration, Oral; D000336:Aerosols; D000402:Airway Obstruction / Q000188:drug therapy; D000605:Amino Alcohols / Q000627:therapeutic use*; D001980:Bronchi / Q000187:drug effects; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002396:Catechols / Q000627:therapeutic use*; D003692:Delayed-Action Preparations; D004106:Dilatation; D004809:Ephedrine / Q000627:therapeutic use; D004983:Ethanolamines / Q000627:therapeutic use; D006801:Humans; D007545:Isoproterenol / Q000627:therapeutic use; D008173:Lung Diseases, Obstructive / Q000188:drug therapy*; D009921:Metaproterenol / Q000627:therapeutic use; D009119:Muscle Contraction; D010919:Placebos; D011674:Pulse / Q000187:drug effects; D012119:Respiration / Q000187:drug effects; D013147:Spirometry; D013566:Sympathomimetics / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D013997:Time Factors
D000336:Aerosols; D000605:Amino Alcohols; D001993:Bronchodilator Agents; D002396:Catechols; D003692:Delayed-Action Preparations; D004983:Ethanolamines; D010919:Placebos; D013566:Sympathomimetics; D009921:Metaproterenol; D004809:Ephedrine; D007545:Isoproterenol